The World Health Organization has issued new guidance to prevent and control cervical cancer. The new Comprehensive cervical cancer control: a guide to essential practice will be launched at the World Cancer Leaders’ Summit in Melbourne, Australia today.
The WHO recommends to vaccinate girls aged 9 to 13 with two doses of the HPV vaccine to prevent human papillomavirus infection, which is responsible for most cases of cervical cancer. This reduced schedule of two doses has been shown to be as effective as three doses, and the change will make the vaccine easier to administrate, as well as reducing the cost. Today, girls in more than 55 countries are protected by routine HPV vaccine administration.
The organization also called for HPV testing, which, once administered, if a woman screens negative, should not be re-administered for at least five years but will be re-screened within 10.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze